Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CASECRYO
Show more
Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical or veterinary purposes, in particular, for biopreservation, cryostorage for cells and tissues, for use as components of biopharmaceuticals, and for general medical diagnostic use; medical diagnostic biochemical and biological reagents for use in detection or treatment, or other medical purposes
Class 5 – Pharmaceuticals & supplements
Status timeline
- 19 Feb 2022Application filedNew Application Entered
- 30 Nov 2022Assigned to an examining attorneyAssigned To Examiner
- 2 Dec 2022Approved for publicationApproved For Pub - Principal Register
- 14 Mar 2023Office action issuedNon-Final Action Written
- 28 Mar 2023Response to office action filedTeas Response To Office Action Received
- 17 Apr 2023Approved for publicationApproved For Pub - Principal Register
- 23 May 2023Published for oppositionPublished For Opposition
- 8 Aug 2023Registered on the Principal RegisterRegistered-Principal Register
All 29 events
| 2024-02-26 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2024-02-26 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2024-02-26 | Teas Change Of Correspondence Received |
| 2023-08-08 | Registered-Principal Register |
| 2023-08-08 | Notice Of Registration Confirmation Emailed |
| 2023-05-23 | Published For Opposition |
| 2023-05-23 | Official Gazette Publication Confirmation E-Mailed |
| 2023-05-03 | Notification Of Notice Of Publication E-Mailed |
| 2023-04-17 | Approved For Pub - Principal Register |
| 2023-03-30 | Teas/Email Correspondence Entered |
| 2023-03-28 | Teas Response To Office Action Received |
| 2023-03-28 | Correspondence Received In Law Office |
| 2023-03-14 | Non-Final Action Written |
| 2023-03-14 | Non-Final Action E-Mailed |
| 2023-03-14 | Notification Of Non-Final Action E-Mailed |
| 2023-03-06 | Previous Allowance Count Withdrawn |
| 2022-12-20 | Withdrawn From Pub - Og Review Query |
| 2022-12-03 | Notice Of Acceptance Of Amendment To Allege Use E-Mailed |
| 2022-12-02 | Use Amendment Accepted |
| 2022-12-02 | Approved For Pub - Principal Register |
| 2022-11-30 | Assigned To Examiner |
| 2022-09-01 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2022-09-01 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2022-09-01 | Teas Change Of Correspondence Received |
| 2022-03-29 | Use Amendment Filed |
| 2022-03-29 | Amendment To Use Processing Complete |
| 2022-03-28 | Teas Amendment Of Use Received |
| 2022-02-22 | New Application Office Supplied Data Entered |
| 2022-02-19 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical or veterinary purposes, in particular, for biopreservation, cryostorage for cells and tissues, for use as components of biopharmaceuticals, and for general medical diagnostic use; medical diagnostic biochemical and biological reagents for use in detection or treatment, or other medical purposes
First use anywhere 8 Feb 2022 · First use in commerce 22 Mar 2022
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 1 Apr 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.